Immunosens

Immunosens is a developer of electrochemical measurement devices aimed at evaluating biomarkers such as genes, proteins, and cell signals through electrode reactions. The company has pioneered the immunoassay method GLEIA® (Gold Linked Electrochemical Immuno Assay), an innovative detection technology that labels antibodies with gold nanoparticles and quantifies the gold atom content via electrochemical methods. This achieves high-sensitivity detection based on sandwich-type immunoassays. The technology, with its simple system configuration, significantly reduces the size of test kits while greatly improving detection accuracy. It can be applied in scenarios such as point-of-care testing, home health monitoring, and trace biomarker analysis, providing a more portable and precise solution for medical-grade rapid testing. The company’s goal is to create a world of health and longevity.